Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9261538 | Autoimmunity Reviews | 2005 | 6 Pages |
Abstract
A prolonged fetal exposure to dexamethasone was reported to impair cerebral development, but we recently studied 6 children, born to patients treated with dexamathasone because of CHB, showing a normal intelligence quotient. The last 10-year experience shows that fetal exposure to antimalarial drugs should not be regarded as an important risk factor for gestational nor neonatal complications. However, information about long-term outcome of children exposed to immunosuppressive drugs “in utero” are still lacking and more efforts are needed in this research area.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Angela Tincani, Chiara Biasini Rebaioli, Micol Frassi, Marco Taglietti, Roberto Gorla, Ilaria Cavazzana, David Faden, Fabrizio Taddei, Andrea Lojacono, Mario Motta, Laura Trepidi, Pierluigi Meroni, Rolando Cimaz, Anna Ghirardello, Andrea Doria,